Prot. FCR001B2201 (FREEDOM-2): A single-arm, multi-center, exploratory safety and efficacy study of FCR001 cell-based therapy to induce donor-specific tolerance in previously transplanted recipients of a kidney from a living donor, and safety in FCR001don

Project: Research project

Project Details

Effective start/end date8/31/218/31/24


  • CTI Clinical Trial and Consulting Services (FCR001B2201)
  • Regenerex LLC (FCR001B2201)